BioSpace News Archive

Bayer announced today that it has earned recognition as a 2021 Military Friendly ® Employer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200921005013/en/ The designation recognizes the company’s proactive efforts to honor, include and encourage veterans and military members through its workplace policies. Such policies at Bayer include expanding hea

Siemens Healthineers and Novartis collaboration to develop assays supporting Novartis’ therapeutic pipeline. Initial program to focus on development of serum neurofilament light chain (NfL) immunoassay for patients with Multiple Sclerosis (MS) and other neurological diseases. Global distribution on Siemens Healthineers immunoassay platforms.

Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of AirDuo® Digihaler® (fluticasone propionate and salmeterol) inhalation powder and ArmonAir® Digihaler® (fluticasone propionate) inhalation powder, two digital maintenance inhalers for patients with asthma.

Algiax Pharmaceuticals, a clinical-stage biotechnology company focused on development of GABAA receptor modulators for neuropathic pain and other indications with unmet medical need, announced that the first patient has been enrolled in the “CURE” study.

A fungal infection is also known as mycosis. It is a skin disease caused by a fungus. There are a million species of fungi.

Transparency Market Research has published a new report titled, “Global Microscopy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.

Diabetic dogs and cats can live long and healthy lives with proper management and veterinary care.

Sharps Containers are important in terms of handling waste produced by medical institutes and healthcare centers and household waste.

Universal Diagnostics, an in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early, announced that promising new data for its investigational advanced adenoma detection blood test and multi-cancer detection test was presented at the European Society for Medical Oncology Virtual Congress 2020.

Alexion Pharmaceuticals, Inc. announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending marketing authorization in the European Union for a new 100 mg/mL intravenous advanced formulation of ULTOMIRIS®.